FDA Inspection 999796 — Waterstone Pharmaceuticals (Hubei) Co., Ltd.
The FDA completed an inspection of Waterstone Pharmaceuticals (Hubei) Co., Ltd. on January 20, 2017 in Tianmen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 20, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Tianmen (China)